As a Novel Prognostic Marker, Cysteine/histidine-rich 1 (CYHR1) is a Therapeutic Target in Patients with Esophageal Squamous Cell Carcinoma
2017 ◽
Vol 225
(4)
◽
pp. S189
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4199-4199